(VIANEWS) – PANORO ENERGY (PEN.OL), SMARTCRAFT (SMCRT.OL), SAVENCIA (SAVE.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. PANORO ENERGY (PEN.OL)
136.5% sales growth and 9.27% return on equity
Panoro Energy ASA, an independent exploration and production company, engages in the exploration, development, and production of oil and gas properties in Africa. It holds assets in the Equatorial Guinea, Gabon, Tunisia, and South Africa. The company was incorporated in 2009 and is based in London, the United Kingdom.
Earnings Per Share
As for profitability, PANORO ENERGY has a trailing twelve months EPS of kr1.68.
PE Ratio
PANORO ENERGY has a trailing twelve months price to earnings ratio of 16.07. Meaning, the purchaser of the share is investing kr16.07 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.27%.
Sales Growth
PANORO ENERGY’s sales growth is 272.5% for the ongoing quarter and 136.5% for the next.
Volume
Today’s last reported volume for PANORO ENERGY is 24073 which is 94.34% below its average volume of 425890.
Revenue Growth
Year-on-year quarterly revenue growth declined by 12.6%, now sitting on 180.27M for the twelve trailing months.
More news about PANORO ENERGY.
2. SMARTCRAFT (SMCRT.OL)
24.1% sales growth and 9.28% return on equity
SmartCraft ASA provides software solutions to the construction industry in Norway, Sweden, and Finland. The company offers Cordel; Bygglet, a SaaS born in the cloud solution; EL-VIS, a solution for electricians; and Congrid, a cloud-based tool for project management in construction companies. It also provides HomeRun, a digital tool for construction, project communication, document, and procurement management; Kvalitetskontroll, a cloud-based project management solution and quality assurance platform for construction companies; El-verdi, a digital sales tool for electricians; and ELinn, a cloud based solution for electricians to handle project management services. The company was founded in 1987 and is headquartered in Hønefoss, Norway.
Earnings Per Share
As for profitability, SMARTCRAFT has a trailing twelve months EPS of kr0.39.
PE Ratio
SMARTCRAFT has a trailing twelve months price to earnings ratio of 53.85. Meaning, the purchaser of the share is investing kr53.85 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.28%.
More news about SMARTCRAFT.
3. SAVENCIA (SAVE.PA)
16.8% sales growth and 4.84% return on equity
Savencia SA produces, distributes, and markets dairy and cheese products in France, rest of Europe, and internationally. It offers butters and creams for the retail market and catering professionals; and dairy ingredients for the food, nutrition, and healthcare industries. The company provides its products under the Caprice des Dieux, Saint Albray, Le Rustique, Cœur de Lion, Saint Agur, Bresse Bleu, PDO Roquefort Papillon, St-Morêt, Tartare, Carré Frais, Apérivrais, Chavroux, Saint-Loup, RichesMonts raclette, Géramont, Saint Albray, Fol Epi, Bresso, Milkana, Brunch, Lucina, Král Sýru, Medve, Alouette and Rogue Creamery, Polenghi, Corman, Balade, and Elle & Vire brands. The company was formerly known as Bongrain SA and changed its name to Savencia SA in April 2015. The company was founded in 1956 and is headquartered in Viroflay, France. Savencia SA is a subsidiary of SAVENCIA Holding SCA.
Earnings Per Share
As for profitability, SAVENCIA has a trailing twelve months EPS of €6.39.
PE Ratio
SAVENCIA has a trailing twelve months price to earnings ratio of 9.77. Meaning, the purchaser of the share is investing €9.77 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.84%.
Sales Growth
SAVENCIA’s sales growth is 16.8% for the present quarter and 16.8% for the next.
More news about SAVENCIA.
4. MEDISTIM (MEDI.OL)
16.7% sales growth and 31.89% return on equity
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.62.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 43.5. Meaning, the purchaser of the share is investing kr43.5 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.89%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.3%, now sitting on 499.39M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 17.7% and positive 11.1% for the next.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Apr 25, 2023, the estimated forward annual dividend rate is 4.5 and the estimated forward annual dividend yield is 1.54%.
More news about MEDISTIM.
5. DSM KON (DSM.AS)
13.1% sales growth and 4.69% return on equity
DSM-Firmenich AG, a science-based company, engages in health and nutrition businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Animal Nutrition & Health (ANH); Health, Nutrition & Care (HNC); and Food & Beverage segments. The Animal Nutrition & Health segment offers essential products, including vitamins, premixes, and carotenoids; performance solutions, such as enzymes, microbes, and eubiotics; precision services comprising support with data analysis to measure animal health and environmental footprint on farm level and feed safety; and methane reducing feed additive for ruminants. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, personal care and aroma, and biomedical materials markets. It offers vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, and sunscreen filters, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise, and customized solutions. The Food & Beverage segment provides ingredients and solutions for use in a range of food products, such as dairy; bakery, cereals, and bars; savory foods; beverages and brewing; confectionery and fruit; plant-based meat and fish alternatives; and petfood. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.
Earnings Per Share
As for profitability, DSM KON has a trailing twelve months EPS of €6.23.
PE Ratio
DSM KON has a trailing twelve months price to earnings ratio of 18.38. Meaning, the purchaser of the share is investing €18.38 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.69%.
Moving Average
DSM KON’s value is above its 50-day moving average of €114.47 and under its 200-day moving average of €121.27.
Yearly Top and Bottom Value
DSM KON’s stock is valued at €114.50 at 17:20 EST, way below its 52-week high of €164.00 and higher than its 52-week low of €105.80.
Revenue Growth
Year-on-year quarterly revenue growth declined by 9.4%, now sitting on 8.39B for the twelve trailing months.
More news about DSM KON.
